Logo

Nassim Usma, Paul M. Meister

Apr 13, 2007
Premium
RXi Pharmaceuticals this week announced that Nassim Usman has joined its scientific advisory board. Usman is currently CEO and a director of Catalyst Biosciences. Prior to joining Catalyst, he was an entrepreneur-in-residence at Morgenthaler Ventures.
 
Usman previously held several positions during his 13-year tenure at Sirna. Usman is currently a member of the scientific advisory board of Noxxon Pharma.
 
 
Thermo Fisher Scientific this week announced that Paul M. Meister, chairman of the board and former vice chairman of Fisher Scientific International, decided to retire from the company’s board of directors. 
 
The company also announced that Meister has relinquished his position as chairman of the board.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.